VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1543024
Sex: F
Age:
State: ME

Vax Date:
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sick to her stomach; Having diarrhea; Severe muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Sick to her stomach), DIARRHOEA (Having diarrhea) and MYALGIA (Severe muscle pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (Sick to her stomach), DIARRHOEA (Having diarrhea) and MYALGIA (Severe muscle pain). At the time of the report, ABDOMINAL DISCOMFORT (Sick to her stomach), DIARRHOEA (Having diarrhea) and MYALGIA (Severe muscle pain) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication were not reported by the reporter. Treatment details not reported by the reporter.

Other Meds:

Current Illness:

ID: 1543025
Sex: F
Age:
State:

Vax Date: 01/18/2021
Onset Date: 01/20/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (CHILLS) and HEADACHE (HEADACHE) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. No Medical History information was reported. On 18-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced CHILLS (CHILLS) and HEADACHE (HEADACHE). At the time of the report, CHILLS (CHILLS) and HEADACHE (HEADACHE) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1543026
Sex: U
Age:
State: NY

Vax Date:
Onset Date: 01/19/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Took the vaccine and had a reaction to it; A spontaneous report was received from a consumer, regarding a patient of unspecified age and gender, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a reaction. The patient medical history was not reported. Concomitant medications were not provided. On an unknown date, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route in unknown for prophylaxis of COVID-19 infection. On 19-Jan-2021, after vaccine administration, the patient experienced reactio. Action taken with mRNA-1273 in response to the event was not provided. The outcome of the events took the vaccine and had a reaction to it was not provided.; Reporter's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.

Other Meds:

Current Illness:

ID: 1543027
Sex: F
Age: 60
State:

Vax Date: 01/09/2021
Onset Date: 01/17/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Had some bruising; warm to the touch; intense itching; it was swell; Very red; very tender; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE BRUISING (Had some bruising), VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE PRURITUS (intense itching), VACCINATION SITE SWELLING (it was swell) and VACCINATION SITE ERYTHEMA (Very red) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was reported by the reporter. Concomitant products included VALSARTAN and ATORVASTATIN for an unknown indication. On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced VACCINATION SITE BRUISING (Had some bruising), VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE PRURITUS (intense itching), VACCINATION SITE SWELLING (it was swell), VACCINATION SITE ERYTHEMA (Very red) and VACCINATION SITE PAIN (very tender). At the time of the report, VACCINATION SITE BRUISING (Had some bruising), VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE PRURITUS (intense itching), VACCINATION SITE SWELLING (it was swell), VACCINATION SITE ERYTHEMA (Very red) and VACCINATION SITE PAIN (very tender) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment included Benadryl and ibuprofen.

Other Meds: VALSARTAN; ATORVASTATIN

Current Illness:

ID: 1543028
Sex: F
Age: 60
State: MI

Vax Date: 12/24/2020
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: flu-like symptoms; weakness; A spontaneous report was received from a consumer concerning a 60-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced influenza-like illness and asthenia. The patient has a history of hypertension. No relevant concomitant medications were reported. Other medications included HCTZ, Prevacid, Adderall, Cerezyme. The patient received their first of two planned doses of mRNA-1273 on 24-Dec-2020. On 18-Jan-2021, the patient received their second of two planned doses of mRNA-1273 (lot/batch: 02620A) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 24-Dec-2020, the patient experienced influenza-like illness and asthenia. Treatment for the event included Tylenol. Action taken with mRNA-1273 in response to the events was not reported. At the time of this report, the outcome of the events (influenza-like illness and asthenia) was unknown.

Other Meds:

Current Illness: Hypertension.

ID: 1543029
Sex: U
Age:
State:

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I called sick for 2 days; complete loss of appetite; Fever 101.7F; Headache; body ache; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (I called sick for 2 days), DECREASED APPETITE (complete loss of appetite), PYREXIA (Fever 101.7F), HEADACHE (Headache) and MYALGIA (body ache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for covid-19 vaccination. The patient's past medical history included No adverse event. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION COMPLICATION (I called sick for 2 days), DECREASED APPETITE (complete loss of appetite), PYREXIA (Fever 101.7F), HEADACHE (Headache) and MYALGIA (body ache). On 08-Jan-2021, VACCINATION COMPLICATION (I called sick for 2 days), DECREASED APPETITE (complete loss of appetite), PYREXIA (Fever 101.7F), HEADACHE (Headache) and MYALGIA (body ache) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Jan-2021, Body temperature: 101.7 (Inconclusive) Body temperature-101.7. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication were not reported by the reporter. Treatment details was not reported by the reporter.

Other Meds:

Current Illness:

ID: 1543030
Sex: F
Age:
State: CA

Vax Date: 01/16/2021
Onset Date: 01/17/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Strong headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Strong headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 16-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced HEADACHE (Strong headache). At the time of the report, HEADACHE (Strong headache) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication were not reported by the reporter. Treatment included 800 mg of Tylenol.

Other Meds:

Current Illness:

ID: 1543031
Sex: M
Age: 78
State: CA

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; a little fever; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (sore arm) and PYREXIA (a little fever) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 41L20A) for COVID-19 vaccination. No Medical History information was reported. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced INJECTION SITE PAIN (sore arm) and PYREXIA (a little fever). At the time of the report, INJECTION SITE PAIN (sore arm) and PYREXIA (a little fever) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1543032
Sex: U
Age:
State:

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: cramps; nauseous; rash; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (cramps), NAUSEA (nauseous) and VACCINATION SITE RASH (rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse reaction. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced MUSCLE SPASMS (cramps), NAUSEA (nauseous) and VACCINATION SITE RASH (rash). At the time of the report, MUSCLE SPASMS (cramps), NAUSEA (nauseous) and VACCINATION SITE RASH (rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication details were not reported by the reporter. Treatment details not reported by the reporter.

Other Meds:

Current Illness:

ID: 1543033
Sex: F
Age: 82
State: FL

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced DIZZINESS (Dizzy). At the time of the report, DIZZINESS (Dizzy) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication were not reported by the reporter. Treatment details was not reported by the reporter.

Other Meds:

Current Illness:

ID: 1543034
Sex: F
Age: 71
State: FL

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: her arm blew up with edema (moderate); Hives; likely experienced an allergic reaction; arm itching; arm redness; typical arm pain; arm swelling; Chills; Fatigue; a swollen lymph node on same side of injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of OEDEMA PERIPHERAL (her arm blew up with edema (moderate)), URTICARIA (Hives), HYPERSENSITIVITY (likely experienced an allergic reaction), PRURITUS (arm itching) and ERYTHEMA (arm redness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Chronic urticaria (18 years ago). Concurrent medical conditions included High cholesterol. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for High cholesterol, VALACYCLOVIR [VALACICLOVIR], ALPRAZOLAM (XANAX) and VITAMINS NOS for an unknown indication. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (typical arm pain), VACCINATION SITE SWELLING (arm swelling), CHILLS (Chills), FATIGUE (Fatigue) and LYMPHADENOPATHY (a swollen lymph node on same side of injection site). On 14-Jan-2021, the patient experienced OEDEMA PERIPHERAL (her arm blew up with edema (moderate)), URTICARIA (Hives), HYPERSENSITIVITY (likely experienced an allergic reaction), PRURITUS (arm itching) and ERYTHEMA (arm redness). On 09-Jan-2021, VACCINATION SITE PAIN (typical arm pain), VACCINATION SITE SWELLING (arm swelling), CHILLS (Chills), FATIGUE (Fatigue) and LYMPHADENOPATHY (a swollen lymph node on same side of injection site) had resolved. At the time of the report, OEDEMA PERIPHERAL (her arm blew up with edema (moderate)), URTICARIA (Hives) and HYPERSENSITIVITY (likely experienced an allergic reaction) outcome was unknown and PRURITUS (arm itching) and ERYTHEMA (arm redness) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment included Benadryl and Tylenol. Primary health care professional suggested diphenhydramine hydrochloride and paracetamol as treatment. The doctor stated that is likely an allergic reaction. It was reported that the events began to improve; but was still experiencing a red, itchy arm that is painful, but the events are "going down". Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: Email address updated

Other Meds: CRESTOR; VALACYCLOVIR [VALACICLOVIR]; XANAX; VITAMINS NOS

Current Illness: High cholesterol

ID: 1543035
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (contracted COVID-19 after receiving the first dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No adverse event). On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (contracted COVID-19 after receiving the first dose). At the time of the report, SARS-COV-2 TEST POSITIVE (contracted COVID-19 after receiving the first dose) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.

Other Meds:

Current Illness:

ID: 1543036
Sex: F
Age: 80
State: OK

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Flu-like symptoms; Her oxygen level dropped to 80mm Hg because she is asthmatic; Swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), OXYGEN SATURATION DECREASED (Her oxygen level dropped to 80mm Hg because she is asthmatic) and VACCINATION SITE SWELLING (Swelling at the injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Asthmatic (Reported but start date and stop date not provided). On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), OXYGEN SATURATION DECREASED (Her oxygen level dropped to 80mm Hg because she is asthmatic) and VACCINATION SITE SWELLING (Swelling at the injection site). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), OXYGEN SATURATION DECREASED (Her oxygen level dropped to 80mm Hg because she is asthmatic) and VACCINATION SITE SWELLING (Swelling at the injection site) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication details were not reported by the reporter. Treatment details were not reported by the reporter.

Other Meds:

Current Illness:

ID: 1543037
Sex: F
Age: 30
State: TX

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: patient voluntarily enrolled in pregnancy registry; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (patient voluntarily enrolled in pregnancy registry) in a 30-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The patient's past medical history included Alcohol use (a couple drinks a week maximum) and UTI (During this pregnancy resolved with antibiotic). Concurrent medical conditions included Drug hypersensitivity (Sulfa), Seasonal allergy and Asthma (Patient was without treatment for ~15 years) since 1994. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]), CETIRIZINE HYDROCHLORIDE (ZYRTEC), FISH OIL and PLANTAGO OVATA (METAMUCIL FIBER) for an unknown indication. On 27-Jan-2021 at 12:25 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 17-Mar-2021. On 27-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (patient voluntarily enrolled in pregnancy registry). On 27-Jan-2021, EXPOSURE DURING PREGNANCY (patient voluntarily enrolled in pregnancy registry) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. At 20 weeks of this pregnancy, low line placenta started and resolve at 30 weeks. On unknown data diagnostic results for glucose test, ultrasound and genetic test were normal. The patient called to enroll herself in pregnancy registry. Most recent FOLLOW-UP information incorporated above includes: On 27-Jan-2021: Internal review on 21-Jul-2021 resulted in the update of birth type, fetal outcome and narrative.

Other Meds: PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]; ZYRTEC; FISH OIL; METAMUCIL FIBER

Current Illness: Asthma (Patient was without treatment for ~15 years); Drug hypersensitivity (Sulfa); Seasonal allergy

ID: 1543038
Sex: F
Age: 80
State: TN

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Face being red and hot; Stiff neck; Dizziness; Weakness; Hardly able to move; Loss of appetite; Diarrhea; Couldn't think right; Severe headache; Fatigue; Chills; Body aches and muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Face being red and hot), MUSCULOSKELETAL STIFFNESS (Stiff neck), DIZZINESS (Dizziness), ASTHENIA (Weakness) and MOBILITY DECREASED (Hardly able to move) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Pacemaker insertion (cardiac) since an unknown date. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced FLUSHING (Face being red and hot), MUSCULOSKELETAL STIFFNESS (Stiff neck), DIZZINESS (Dizziness), ASTHENIA (Weakness), MOBILITY DECREASED (Hardly able to move), DECREASED APPETITE (Loss of appetite), DIARRHOEA (Diarrhea), THINKING ABNORMAL (Couldn't think right), HEADACHE (Severe headache), FATIGUE (Fatigue), CHILLS (Chills) and MYALGIA (Body aches and muscle aches). On 18-Jan-2021, FLUSHING (Face being red and hot), MUSCULOSKELETAL STIFFNESS (Stiff neck), DIZZINESS (Dizziness), ASTHENIA (Weakness), MOBILITY DECREASED (Hardly able to move), DECREASED APPETITE (Loss of appetite), DIARRHOEA (Diarrhea), THINKING ABNORMAL (Couldn't think right), HEADACHE (Severe headache), FATIGUE (Fatigue), CHILLS (Chills) and MYALGIA (Body aches and muscle aches) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications reported. Treatment of the events included Benadryl. Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: Follow up report received on 13APR2021 included the patient's second dose information for the suspect drug.

Other Meds:

Current Illness: Pacemaker insertion (cardiac)

ID: 1543039
Sex: F
Age: 35
State: OH

Vax Date: 01/07/2021
Onset Date: 01/15/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: warm, red welt at the injection site; Red welt at the injection site of the size of golf ball with indefinite margin; warm, red welt at the injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE WARMTH (warm, red welt at the injection site), VACCINATION SITE URTICARIA (Red welt at the injection site of the size of golf ball with indefinite margin) and VACCINATION SITE ERYTHEMA (warm, red welt at the injection site) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE WARMTH (warm, red welt at the injection site), VACCINATION SITE URTICARIA (Red welt at the injection site of the size of golf ball with indefinite margin) and VACCINATION SITE ERYTHEMA (warm, red welt at the injection site). At the time of the report, VACCINATION SITE WARMTH (warm, red welt at the injection site) had not resolved and VACCINATION SITE URTICARIA (Red welt at the injection site of the size of golf ball with indefinite margin) and VACCINATION SITE ERYTHEMA (warm, red welt at the injection site) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication details were not reported by the reporter. Treatment included Benadryl oral and Benadryl topical cream.

Other Meds:

Current Illness:

ID: 1543040
Sex: F
Age: 77
State: CT

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: muscle soreness in her arm (injection site); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (muscle soreness in her arm (injection site)) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE PAIN (muscle soreness in her arm (injection site)). At the time of the report, VACCINATION SITE PAIN (muscle soreness in her arm (injection site)) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication were not reported by the reporter. Treatment details was not reported by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1543041
Sex: M
Age:
State: AZ

Vax Date:
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm soreness; headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm soreness) and HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (arm soreness) and HEADACHE (headache). At the time of the report, VACCINATION SITE PAIN (arm soreness) and HEADACHE (headache) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication were not reported by the reporter. Treatment details were not reported by the reporter.

Other Meds:

Current Illness:

ID: 1543042
Sex: F
Age:
State:

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: a bit of a rash, like an allergy but not really bad; The injection site got itchy; The injection site got red; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (The injection site got itchy), VACCINATION SITE ERYTHEMA (The injection site got red) and VACCINATION SITE RASH (a bit of a rash, like an allergy but not really bad) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported.). In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE PRURITUS (The injection site got itchy) and VACCINATION SITE ERYTHEMA (The injection site got red). On an unknown date, the patient experienced VACCINATION SITE RASH (a bit of a rash, like an allergy but not really bad). At the time of the report, VACCINATION SITE PRURITUS (The injection site got itchy), VACCINATION SITE ERYTHEMA (The injection site got red) and VACCINATION SITE RASH (a bit of a rash, like an allergy but not really bad) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications were not reported by the reporter. Treatment included Claritin. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1543043
Sex: F
Age:
State: FL

Vax Date:
Onset Date: 01/19/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash around the area of the vaccine; This spontaneous case was reported by an attorney and describes the occurrence of VACCINATION SITE RASH (Rash around the area of the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash around the area of the vaccine). At the time of the report, VACCINATION SITE RASH (Rash around the area of the vaccine) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication details were not reported by the reporter. Treatment details not reported by the reporter.

Other Meds:

Current Illness:

ID: 1543044
Sex: F
Age:
State: OH

Vax Date: 01/11/2021
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection site is warm; Injection site is red; Injection site is raised; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Injection site is warm), VACCINATION SITE ERYTHEMA (Injection site is red) and VACCINATION SITE SWELLING (Injection site is raised) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported.). On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site is warm), VACCINATION SITE ERYTHEMA (Injection site is red) and VACCINATION SITE SWELLING (Injection site is raised). At the time of the report, VACCINATION SITE WARMTH (Injection site is warm), VACCINATION SITE ERYTHEMA (Injection site is red) and VACCINATION SITE SWELLING (Injection site is raised) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication details were not reported by the reporter. Treatment details were not provided by the reporter. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1543045
Sex: M
Age:
State: TX

Vax Date: 01/08/2021
Onset Date: 01/18/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. No Medical History information was reported. On 08-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication details were not reported by the reporter. Treatment medication details was not reported by the reporter.

Other Meds:

Current Illness:

ID: 1543046
Sex: F
Age: 69
State:

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Epidural injection (in order to mitigate back aches.). Concurrent medical conditions included Back ache. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication included back injections to treat back-aches. Treatment information was not provided by the reporter.

Other Meds:

Current Illness: Back ache

ID: 1543047
Sex: F
Age: 79
State: NC

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: severe headaches; Face was hot; vision issues; a screen/wire appears over eyes; Vomiting, difficulty to keep food down; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Face was hot), VISUAL IMPAIRMENT (vision issues; a screen/wire appears over eyes), VOMITING (Vomiting, difficulty to keep food down) and HEADACHE (severe headaches) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. No medical history was reported by the reporter. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced FLUSHING (Face was hot), VISUAL IMPAIRMENT (vision issues; a screen/wire appears over eyes), VOMITING (Vomiting, difficulty to keep food down) and HEADACHE (severe headaches). At the time of the report, FLUSHING (Face was hot), VISUAL IMPAIRMENT (vision issues; a screen/wire appears over eyes), VOMITING (Vomiting, difficulty to keep food down) and HEADACHE (severe headaches) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication were blood thinner, thyroid medication and baby aspirin. Treatment details included Tylenol and Ondansetron HCL 4 mg tablets.

Other Meds: BABY ASPIRIN

Current Illness:

ID: 1543048
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Started out as 2 pustules and then turned red; Red mark/2 inches in diameter; This spontaneous case was reported by a consumer and describes the occurrence of PUSTULE (Started out as 2 pustules and then turned red) and ERYTHEMA (Red mark/2 inches in diameter) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PUSTULE (Started out as 2 pustules and then turned red) and ERYTHEMA (Red mark/2 inches in diameter). At the time of the report, PUSTULE (Started out as 2 pustules and then turned red) and ERYTHEMA (Red mark/2 inches in diameter) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1543049
Sex: F
Age: 73
State: FL

Vax Date: 01/02/2021
Onset Date: 01/02/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Very warm; arm was swollen; very red,; discomfort from the actual shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (discomfort from the actual shot), VACCINATION SITE WARMTH (Very warm), VACCINATION SITE SWELLING (arm was swollen) and VACCINATION SITE ERYTHEMA (very red,) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no relevant medical history provided). On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jan-2021, the patient experienced VACCINATION SITE DISCOMFORT (discomfort from the actual shot). On 11-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Very warm), VACCINATION SITE SWELLING (arm was swollen) and VACCINATION SITE ERYTHEMA (very red,). On 04-Jan-2021, VACCINATION SITE DISCOMFORT (discomfort from the actual shot) had resolved. At the time of the report, VACCINATION SITE WARMTH (Very warm), VACCINATION SITE SWELLING (arm was swollen) and VACCINATION SITE ERYTHEMA (very red,) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication were not reported by the reporter. Treatment details included ice, antibiotics and Benadryl.

Other Meds:

Current Illness:

ID: 1543050
Sex: F
Age:
State: GA

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), ABDOMINAL DISCOMFORT (Stomach upset), ERUCTATION (Burping), FATIGUE (Fatigue) and MYALGIA (Bad body aches) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was reported by the reporter. Concomitant products included LISINOPRIL, ROSUVASTATIN CALCIUM (CRESTOR), TRIAMCINOLONE ACETONIDE (NASACORT), CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), SALBUTAMOL (ALBUTEROL HFA), COQ10 [ASCORBIC ACID;BETACAROTENE;CUPRIC OXIDE;MANGANESE SULFATE;SELENIUM;TOCOPHERYL ACETATE;UBIDECARENONE;ZINC OXIDE] and MULTIVITAMIN [VITAMINS NOS] for an unknown indication. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), ABDOMINAL DISCOMFORT (Stomach upset), ERUCTATION (Burping), FATIGUE (Fatigue), MYALGIA (Bad body aches), CHILLS (Chills) and PYREXIA (Fever). On an unknown date, the patient experienced NAUSEA (Nausea). At the time of the report, PAIN IN EXTREMITY (Sore arm), ABDOMINAL DISCOMFORT (Stomach upset), FATIGUE (Fatigue), MYALGIA (Bad body aches) and CHILLS (Chills) had not resolved and ERUCTATION (Burping), NAUSEA (Nausea) and PYREXIA (Fever) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment included Tylenol 500 mg.

Other Meds: LISINOPRIL; CRESTOR; NASACORT; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; ALBUTEROL HFA; COQ10 [ASCORBIC ACID;BETACAROTENE;CUPRIC OXIDE;MANGANESE SULFATE;SELENIUM;TOCOPHERYL ACETATE;UBIDECA; MULTIVITAMIN [VITAMINS NOS]

Current Illness:

ID: 1543051
Sex: F
Age: 34
State: CT

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: warm to touch; itchy; a red area at the injection site; it is a little smaller than palm size; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of INJECTION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (itchy), INJECTION SITE ERYTHEMA (a red area at the injection site) and INJECTION SITE SWELLING (it is a little smaller than palm size) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history provided.). On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced INJECTION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (itchy), INJECTION SITE ERYTHEMA (a red area at the injection site) and INJECTION SITE SWELLING (it is a little smaller than palm size). At the time of the report, INJECTION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (itchy) and INJECTION SITE SWELLING (it is a little smaller than palm size) outcome was unknown and INJECTION SITE ERYTHEMA (a red area at the injection site) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication details were not reported by the reporter. Treatment included Pepcid.

Other Meds:

Current Illness:

ID: 1543052
Sex: F
Age: 76
State: NV

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lethargy; Sore arm; Headache; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargy), PAIN IN EXTREMITY (Sore arm), HEADACHE (Headache) and FATIGUE (Tiredness) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination. The patient's past medical history included COVID-19 in October 2019. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced LETHARGY (Lethargy), PAIN IN EXTREMITY (Sore arm), HEADACHE (Headache) and FATIGUE (Tiredness). At the time of the report, LETHARGY (Lethargy), PAIN IN EXTREMITY (Sore arm), HEADACHE (Headache) and FATIGUE (Tiredness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication were not reported by the reporter. Treatment details was not reported by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1543053
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (adverse reaction). At the time of the report, VACCINATION COMPLICATION (adverse reaction) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment related information has been reported.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.

Other Meds:

Current Illness:

ID: 1543054
Sex: F
Age: 63
State: KS

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tired; fever (99.4?F) for 3 days; No energy; No appetite; Felt rough; Nausea; Chills; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Jan-2021. The most recent information was received on 07-Jun-2021 and was forwarded to Moderna on 07-Jun-2021. This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (No energy), DECREASED APPETITE (No appetite), FEELING ABNORMAL (Felt rough), NAUSEA (Nausea) and CHILLS (Chills) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Drug allergy (Allergy to sulfa) and Allergic reaction to antibiotics (Allergy to Amoxicillin). On 15-Jan-2021 at 8:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced ASTHENIA (No energy), DECREASED APPETITE (No appetite), FEELING ABNORMAL (Felt rough), NAUSEA (Nausea), CHILLS (Chills) and PYREXIA (fever (99.4?F) for 3 days). On 19-Jan-2021, the patient experienced FATIGUE (Tired). On 17-Jan-2021, ASTHENIA (No energy), DECREASED APPETITE (No appetite), FEELING ABNORMAL (Felt rough), NAUSEA (Nausea) and CHILLS (Chills) had resolved. On 19-Jan-2021, PYREXIA (fever (99.4?F) for 3 days) had resolved. At the time of the report, FATIGUE (Tired) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Nov-2020, SARS-CoV-2 test: positive (Positive) rapid & sent to state. On 16-Jan-2021, Body temperature: 99.4?f (High) 99.4?F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment related information has been reported. Patient was likely to buy hearing aid for left ear. This case was linked to MOD-2021-053892 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Follow-up received on 07-Jun-2021 contains Patient demographic details, Medical History, second dose details, vaccine information.

Other Meds:

Current Illness: Allergic reaction to antibiotics (Allergy to Amoxicillin); Drug allergy (Allergy to sulfa.)

ID: 1543055
Sex: F
Age: 72
State: TX

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Mouth tingling / Lips tingling; Horrible taste of metal in mouth; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA ORAL (Mouth tingling / Lips tingling) and DYSGEUSIA (Horrible taste of metal in mouth) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PARAESTHESIA ORAL (Mouth tingling / Lips tingling) and DYSGEUSIA (Horrible taste of metal in mouth). At the time of the report, PARAESTHESIA ORAL (Mouth tingling / Lips tingling) and DYSGEUSIA (Horrible taste of metal in mouth) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. About 20 minutes after receiving the shot, the patient started feeling tingling around her month and lips. In addition, she had a horrible taste of metal in her mouth. No relevant concomitant medications were reported. No treatment information was provided. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1543056
Sex: F
Age: 65
State: CA

Vax Date: 01/16/2021
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (very itchy), LYMPHADENOPATHY (swelling in her armpit) and VACCINATION SITE ERYTHEMA (arm very red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes and Blood pressure. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) and CLONAZEPAM for an unknown indication. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (very itchy), LYMPHADENOPATHY (swelling in her armpit) and VACCINATION SITE ERYTHEMA (arm very red). At the time of the report, PRURITUS (very itchy), LYMPHADENOPATHY (swelling in her armpit) and VACCINATION SITE ERYTHEMA (arm very red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitantly patient was taking steroids, blood pressure medications and diabetes medications. No treatment related information has been reported.

Other Meds: BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]; CLONAZEPAM

Current Illness: Blood pressure; Diabetes

ID: 1543057
Sex: F
Age:
State:

Vax Date: 01/10/2021
Onset Date: 01/18/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: a little bit of itchiness at injection site; a little bit of swelling at injection site; a little bit of redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (a little bit of itchiness at injection site), VACCINATION SITE SWELLING (a little bit of swelling at injection site) and VACCINATION SITE ERYTHEMA (a little bit of redness at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (a little bit of itchiness at injection site), VACCINATION SITE SWELLING (a little bit of swelling at injection site) and VACCINATION SITE ERYTHEMA (a little bit of redness at injection site). At the time of the report, VACCINATION SITE PRURITUS (a little bit of itchiness at injection site), VACCINATION SITE SWELLING (a little bit of swelling at injection site) and VACCINATION SITE ERYTHEMA (a little bit of redness at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment related information has been reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1543058
Sex: M
Age: 37
State: TX

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Body ache; Fatigue; Chills; Fever 102; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body ache), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever 102) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 15-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced MYALGIA (Body ache), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever 102). At the time of the report, MYALGIA (Body ache), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever 102) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Body temperature: 102. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. Treatment medication included acetaminophen 4-6 daily.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1543059
Sex: F
Age:
State: AZ

Vax Date:
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain in the ear; This spontaneous case was reported by an other health care professional and describes the occurrence of EAR PAIN (pain in the ear) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EAR PAIN (pain in the ear). At the time of the report, EAR PAIN (pain in the ear) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not provided. Treatment information was not reported.

Other Meds:

Current Illness:

ID: 1543060
Sex: M
Age:
State: NJ

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm is little sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes, Hypertension and Gout. Concomitant products included METFORMIN, AMLODIPINE and VALSARTAN for an unknown indication. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was not reported.

Other Meds: METFORMIN; AMLODIPINE; VALSARTAN

Current Illness: Diabetes; Gout; Hypertension

ID: 1543061
Sex: F
Age: 79
State: FL

Vax Date: 01/07/2021
Onset Date: 01/09/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Very disoriented; Equilibrium was off; BP was 244; Extreme fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DISORIENTATION (Very disoriented), BALANCE DISORDER (Equilibrium was off), HYPERTENSION (BP was 244) and FATIGUE (Extreme fatigue) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The patient's past medical history included Hysterectomy. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced DISORIENTATION (Very disoriented), BALANCE DISORDER (Equilibrium was off), HYPERTENSION (BP was 244) and FATIGUE (Extreme fatigue). On 14-Jan-2021, DISORIENTATION (Very disoriented), BALANCE DISORDER (Equilibrium was off), HYPERTENSION (BP was 244) and FATIGUE (Extreme fatigue) was resolving. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Jan-2021, Blood pressure measurement: 244. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient was 40 years old when she had a hysterectomy, which was the only surgery she had in her life. That time she felt her equilibrium was off, which lasted days. Not until 16-Jan-2021, she was able to walk unassisted. She saw her physician on 12-Jan-2021 and her pressure had gone down. She was feeling better. She was not allergic to anything. The patient had a follow up appointment with her physician on 26-Jan-2021. Concomitant medications were not provided. Treatment information was not reported.

Other Meds:

Current Illness:

ID: 1543062
Sex: M
Age:
State: GA

Vax Date: 01/18/2021
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever of 103 F degrees; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 103 F degrees) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever of 103 F degrees). At the time of the report, PYREXIA (fever of 103 F degrees) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. Treatment information was not reported.

Other Meds:

Current Illness:

ID: 1543063
Sex: F
Age: 53
State: NY

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced VACCINATION SITE PAIN (Mild soreness at the injection site) and VACCINATION SITE SWELLING (Slight swelling at the injection site). On 19-Jan-2021, the patient experienced INSOMNIA (Difficulty sleeping), VACCINATION SITE INDURATION (Muscle being hard as rock), VACCINATION SITE PAIN (Pain at injection site/very tender) and VACCINATION SITE SWELLING (Arm more swollen than last week). On 13-Jan-2021, VACCINATION SITE PAIN (Mild soreness at the injection site) and VACCINATION SITE SWELLING (Slight swelling at the injection site) had resolved. At the time of the report, INSOMNIA (Difficulty sleeping), VACCINATION SITE INDURATION (Muscle being hard as rock), VACCINATION SITE PAIN (Pain at injection site/very tender) and VACCINATION SITE SWELLING (Arm more swollen than last week) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The concomitant medications and treatment details were not provided. Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: Follow-up information received on 13-Apr-2021 does not contain any new information. On 23-Apr-2021: Follow-up information received on 23-Apr-2021 does not contain an new information

Other Meds:

Current Illness:

ID: 1543064
Sex: F
Age: 31
State: FL

Vax Date: 12/29/2020
Onset Date: 12/29/2020
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: facial numbness and tingling; brain fog: my head was constantly heavy; felt lightheaded/dizzy; A spontaneous case was received from the consumer concerning female patient of 31 years who received Moderna's COVID-19 vaccine and experienced lightheaded and dizzy/Dizziness, brain fog: my head was constantly heavy/Head discomfort, facial numbness and tingling/Paraesthesia . The patient's medical history was not provided. No relevant concomitant medications was reported. On 29-Jan-2021 prior to the onset of the events, the patient received first of the two planned doses of mRNA-1273 (Lot Number:011520A) on the left arm for the prophylaxis of COVID-19 infection. On 19-Jan-2021 the patient experienced anticipating a sore arm, but she felt lightheaded and dizzy, which lasted a day or two. On 01Jan2021, she had a brain fog; her head was constantly heavy. She can function cognitively, but it takes more to concentrate and accomplish things. She started developing facial numbness and tingling on 13Jan2021. She reports it happens every day most of the day. Action taken with the second dose of mRNA-1273 in response to the event was not reported. The outcome of the events, lightheaded and dizzy/Dizziness was resolved and brain fog: my head was constantly heavy/Head discomfort, facial numbness and tingling/Paraesthesia was not provided.

Other Meds:

Current Illness:

ID: 1543065
Sex: F
Age: 45
State: WA

Vax Date: 01/12/2021
Onset Date: 01/20/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: cough; injection site was very itchy; injection site was swollen; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), VACCINATION SITE PRURITUS (injection site was very itchy) and VACCINATION SITE SWELLING (injection site was swollen) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure. Concomitant products included METHYLPHENIDATE HYDROCHLORIDE (RITALIN) for an unknown indication. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 20-Jan-2021, the patient experienced COUGH (cough), VACCINATION SITE PRURITUS (injection site was very itchy) and VACCINATION SITE SWELLING (injection site was swollen). At the time of the report, COUGH (cough), VACCINATION SITE PRURITUS (injection site was very itchy) and VACCINATION SITE SWELLING (injection site was swollen) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided. Reporter did not allow further contact

Other Meds: RITALIN

Current Illness: Blood pressure

ID: 1543066
Sex: F
Age:
State:

Vax Date: 01/11/2021
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain all the way down to wrist; diizziness was very bothersome, had to lie flat to feel better; Backache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain all the way down to wrist), DIZZINESS POSTURAL (diizziness was very bothersome, had to lie flat to feel better), BACK PAIN (Backache) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain all the way down to wrist), DIZZINESS POSTURAL (diizziness was very bothersome, had to lie flat to feel better), BACK PAIN (Backache) and NAUSEA (Nausea). At the time of the report, PAIN IN EXTREMITY (pain all the way down to wrist), DIZZINESS POSTURAL (diizziness was very bothersome, had to lie flat to feel better), BACK PAIN (Backache) and NAUSEA (Nausea) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient did not seek medical treatment.

Other Meds:

Current Illness:

ID: 1543067
Sex: F
Age: 68
State: FL

Vax Date: 01/06/2021
Onset Date: 01/13/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vaccination site pruritus; Vaccination site rash; This spontaneous case was reported by a consumer and describes the occurrence of in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (no relevant medical history provided). On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1543068
Sex: M
Age: 31
State: TX

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pains/other pain; muscle aches; Headache; Arm pain; Fatigue; Fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), PAIN (pains/other pain), FATIGUE (Fatigue), PYREXIA (Fever) and CHILLS (chills) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm pain), FATIGUE (Fatigue), PYREXIA (Fever) and CHILLS (chills). On 20-Jan-2021, the patient experienced HEADACHE (Headache). On an unknown date, the patient experienced PAIN (pains/other pain) and MYALGIA (muscle aches). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm pain), PAIN (pains/other pain), FATIGUE (Fatigue), PYREXIA (Fever), CHILLS (chills), HEADACHE (Headache) and MYALGIA (muscle aches) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided.

Other Meds:

Current Illness:

ID: 1543069
Sex: F
Age:
State:

Vax Date: 01/06/2021
Onset Date: 01/15/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Extremaly swelling glands on the neck; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Extremaly swelling glands on the neck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced SWELLING (Extremaly swelling glands on the neck). At the time of the report, SWELLING (Extremaly swelling glands on the neck) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications details were not reported by the reported. Treatment details was not reported by the reporter. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1543070
Sex: F
Age: 73
State: NY

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: could not lift the arm and that had no use of left arm; Sweats; pain went from elbow up to the neck , front chest; pain in the arm where the vaccine was given; lymph node was the size of an egg; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PAIN (pain in the arm where the vaccine was given), PAIN (pain went from elbow up to the neck , front chest), LYMPHADENOPATHY (lymph node was the size of an egg), INJECTED LIMB MOBILITY DECREASED (could not lift the arm and that had no use of left arm) and HYPERHIDROSIS (Sweats) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. Concomitant products included Allopyranol, Hydroclorizide, LISINOPRIL and METOPROLOL for an unknown indication. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE PAIN (pain in the arm where the vaccine was given), PAIN (pain went from elbow up to the neck , front chest) and LYMPHADENOPATHY (lymph node was the size of an egg). On 17-Jan-2021, the patient experienced INJECTED LIMB MOBILITY DECREASED (could not lift the arm and that had no use of left arm) and HYPERHIDROSIS (Sweats). At the time of the report, VACCINATION SITE PAIN (pain in the arm where the vaccine was given), PAIN (pain went from elbow up to the neck , front chest), INJECTED LIMB MOBILITY DECREASED (could not lift the arm and that had no use of left arm) and HYPERHIDROSIS (Sweats) was resolving and LYMPHADENOPATHY (lymph node was the size of an egg) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment included none.

Other Meds: Allopyranol; Hydroclorizide; LISINOPRIL; METOPROLOL

Current Illness:

ID: 1543071
Sex: F
Age:
State: CA

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: extremely heated arm at the injection site; A spontaneous report was received from consumer concerning a 81 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced vaccination site warmth. The patient's medical history was not provided. No relevant concomitant medications were reported. On 15 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 041L20A) intramuscularly in the arm for prophylaxis of COVID-19 infection. On 15 Jan 2021, The patient experienced extremely heated arm on the injection site. Laboratory details are not provided. The patient was treated with Benadryl. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the event was unknown.; Reporter's Comments: This case concerns an 81-year-old female who experienced a nonserious unexpected event of vaccination site warmth. The events occurred the same day as the first dose of mRNA-1273 (lot # 041L20A). The patient was treated with Benadryl. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1543072
Sex: F
Age: 77
State: NJ

Vax Date: 01/11/2021
Onset Date: 01/19/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: The site of injection is hot and swollen; Redness and rash at the site of injection; Redness and rash at the site of injection; The site of injection is hot and swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (The site of injection is hot and swollen), VACCINATION SITE ERYTHEMA (Redness and rash at the site of injection), VACCINATION SITE RASH (Redness and rash at the site of injection) and VACCINATION SITE SWELLING (The site of injection is hot and swollen) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. No Medical History information was reported. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE WARMTH (The site of injection is hot and swollen), VACCINATION SITE ERYTHEMA (Redness and rash at the site of injection), VACCINATION SITE RASH (Redness and rash at the site of injection) and VACCINATION SITE SWELLING (The site of injection is hot and swollen). At the time of the report, VACCINATION SITE WARMTH (The site of injection is hot and swollen), VACCINATION SITE ERYTHEMA (Redness and rash at the site of injection), VACCINATION SITE RASH (Redness and rash at the site of injection) and VACCINATION SITE SWELLING (The site of injection is hot and swollen) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1543073
Sex: F
Age: 38
State: CA

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: a little itchiness on the same arm of injection; experienced chills; very bad headaches; felt like she had the flu; bone pain; stay in bed all day; feel very anxious; her hands started to sweat; numbness on face and tongue; tingle on face and tongue like she had anesthesia; tingle on face and tongue like she had anesthesia; tongue was bigger and dryness; tongue was bigger and dryness; thirsty; pressure on chest; dizziness; This spontaneous case was reported by an other caregiver and describes the occurrence of ANXIETY (feel very anxious), HYPERHIDROSIS (her hands started to sweat), HYPOAESTHESIA (numbness on face and tongue), PARAESTHESIA (tingle on face and tongue like she had anesthesia) and PARAESTHESIA ORAL (tingle on face and tongue like she had anesthesia) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced ANXIETY (feel very anxious), HYPERHIDROSIS (her hands started to sweat), HYPOAESTHESIA (numbness on face and tongue), PARAESTHESIA (tingle on face and tongue like she had anesthesia), PARAESTHESIA ORAL (tingle on face and tongue like she had anesthesia), SWOLLEN TONGUE (tongue was bigger and dryness), TONGUE DRY (tongue was bigger and dryness), THIRST (thirsty), CHEST DISCOMFORT (pressure on chest) and DIZZINESS (dizziness). On 17-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (felt like she had the flu), BEDRIDDEN (stay in bed all day), CHILLS (experienced chills), BONE PAIN (bone pain) and HEADACHE (very bad headaches). On 20-Jan-2021, the patient experienced INJECTION SITE PRURITUS (a little itchiness on the same arm of injection). On 16-Jan-2021, ANXIETY (feel very anxious), HYPERHIDROSIS (her hands started to sweat), HYPOAESTHESIA (numbness on face and tongue), PARAESTHESIA (tingle on face and tongue like she had anesthesia), PARAESTHESIA ORAL (tingle on face and tongue like she had anesthesia), SWOLLEN TONGUE (tongue was bigger and dryness), TONGUE DRY (tongue was bigger and dryness), THIRST (thirsty), CHEST DISCOMFORT (pressure on chest) and DIZZINESS (dizziness) had resolved. On 17-Jan-2021, INFLUENZA LIKE ILLNESS (felt like she had the flu), BEDRIDDEN (stay in bed all day), CHILLS (experienced chills), BONE PAIN (bone pain) and HEADACHE (very bad headaches) had resolved. At the time of the report, INJECTION SITE PRURITUS (a little itchiness on the same arm of injection) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm